Ординатура / Офтальмология / Английские материалы / Atlas of Lacrimal Surgery_Weber, Keerl, Della Rocca_2007

Interventional Radiology

Schaudig and Maas (2005), for example, admit that the overall success rate is lower than that reported after conventional dacryocystorhinostomy, yet they draw the conclusion that refinement of the surface and stent design may improve results in the future.

The short-term observation after implantation of the newly designed hydrophilicly coated TearLeader stent has already shown a clear tendency towards more favorable results. This also includes the good feasibility and greater patient comfort during the implantation procedure, as has been shown in our studies (Wilhelm et al. 2003) and in the first longterm clinical results reported by Ferrer-Puchol et al.

(Ferrer-Puchol et al. 2000); however, longer follow-up periods will be required to define the role of stent implantation finally.

13.6 Highlights

Advances in interventional techniques in the lacrimal drainage system have expanded novel procedures for the easy and safe treatment of epiphora. These methods are simple, safe, and cost-effective, and can be performed under local anesthesia on an outpatient basis. They cause no facial scars and fewer problems with bleeding, resulting in less postoperative complications with high patient compliance and contentment.

Fluoroscopically guided balloon dacryocystoplasty is a feasible nonsurgical therapy in nasolacrimal duct stenosis that may be used as first-line therapy. In cases that have initial success, however, a relatively high long-term success rate can be expected.

Stent placement should be selected with caution as a first-line therapeutic option in patients who refuse surgical procedures or are not suitable to general anesthesia. Although the initial results of stent placement in patients with complete obstructions of the lacrimal drainage system are excellent, long-term results have to be improved.

Reference

Becker BB, Berry FD. Balloon catheter dilation in lacrimal surgery. Ophthalmic Surg 1989;20:193<198

Ewing AE. Roentgen ray demonstration of the lacrimal abscess cavity. Am J Ophthalmol 1989;26:1–4

Ferrer-Puchol M, Esteban-Hernández E, Jornet-Frayos J, Fer- ragus-Gibes S, Sanifélix-Micó P, Terol-Penalva D (2005) Obstruction of the lacrimal system. Treatment and long term results with polyurethane Song stent versus Tear Leader-Stent. Annual Meeting and Postgraduate Course of the Cardiovascular and Interventional Radiological Society of Europe, Abstract Book Poster 30, 164

Hofer U, Wilhelm KE, Loeffler K, Schild H. Diagnostic Digital-Subtraction-Dacryozystography: Technique, Criteria of Evaluation, Frequency and Localization of Pathological Findings. Radiology 2000;217(P):223

Huenerbein R, Grass F, Leber M, Wilhelm K, Kuhn FP. Balloon dacryocystoplasty: interventional radiological therapy of congenital dacryostenosis. Rofo 2005; 177:1387–1393

Janssen AG, Mansour K, Rabbe GJ. Dacryocystoplasty: treatment of epiphora by means of ballon dilation of the obstructed nasolacrimal duct system. Radiology 1994;193:453<456 Kang SG, Song HY, Lee DH, Choi JY, Ahn HS. Nonsurgically placed nasolacrimal stents for epiphora: long-term results and factors favoring stent patency. J Vasc Interv Radiol

2002;13:293<300

Kassel EE, Schatz CJ. Lacrimal Apparatus. In: Som PM, Curtin HD (eds) Head and neck imaging, 3rd edn. Mosby, St. Louis, 1995;1129<1183

Ko GY, Song HY et al. Obstruction of the lacrimal system: treatment with a covered, retrievable, expandable nitinol stent versus a lacrimal polyurethane stent. Radiology 2003;227:270–276

Lanciego C, Miguel S de, Perea M et al. Nasolacrimal stents in the management of epiphora: medium-term results of a multicenter prospective study. J Vasc Interv Radiol 2001;12:701–710

Lanciego C, Toledano N et al. Resolution of epiphora with nasolacrimal stents: results of long-term follow-up in a multicenter prospective study. J Vasc Interv Radiol 2003;14:1417<1425

Lanciego C, Bracamonte A, Mendez-Cendon JC, Gomez C, Padilla M, Garcia-Garcia L. Loss of vision as a complication of nasolacrimal stent placement. J Vasc Interv Radiol 2004;15:1027<1028

Lee JM, Song HY, Han YM, Chung GH, Sohn MH, Kim KS, Choi KC. Balloon dacryocystoplasty. Results in the treatment of complete and partial obstructions of the nasolacrimal system. Radiology 1994;192:503–508

Lüchtenberg M, Kuhli C et al. Three-dimensional rotational dacryocystography for imaging of the lacrimal drainage system and adjacent anatomical structures. Ophthalmologia 2005; 219:136<141

Munk PL, Lin DTC, Morris DC. Epiphora: treatment by means of dacryocystoplasty with balloon dilation of the nasolacrimal drainage apparatus. Radiology 1990;177:687–690

Perena MF, Castillo J, Medrano J, Gregorio MA de, Loras E, Cristobal JA. Nasolacrimal polyurethane stent placement: preliminary results. Eur J Ophthalmol 2001;11:25<30

Pinto I, Paul L, Grande C, Cal MA de la. Nasolacrimal polyurethane stent placement for epiphora: technical long-term results. J Vasc Interv Radiol 2001;12:67<71

Schaudig U, Maas R. T he polyurethane nasolacrimal duct stent for lower tear duct obstruction: long-term success rate and complications. Graefes Arch Clin Exp Ophthalmol 2000;238:733<737

Song HY, Jin HY, Kim JH, Sung KB, Han YM, Cho NC. Nasolacrimal duct obstruction treated nonsurgically with use of plastic stents. Radiology 1994;190:535<539

Song HY, Jin Y-H, Kim J-H, Huh S-J, Kim Y-H, Kom T-H, Sung K-B. Nonsurgical placement of a nasolacrimal polyurethane stent. Radiology 1995;194:233<237

Song HY et al. Non-surgical placement of a nasolacrimal polyurethane stent: long-term effectiveness. Radiology 1996;200:759–763

Song, H-Y, Lee DH, Ahn H, Seo T-S, Ko G-Y. Intervention in the lacrimal drainage system. Cardiovasc Intervent Radiol 2002;25:165–170

Wilhelm K, Textor J, Hofer U, Böker T, Strunk H, Schild H. Nasolacrimal duct obstructions: treatment with balloon dilation and stent implantation. Fortschr Röntgenstr 1997;167:486–490

Wilhelm K, Hofer U, Textor J, Böker T, Strunk H, Schild H. Nonsurgical fluoroscopically guided treatment of dacryoliths during dacrycystoplasty. Radiology 1999:212:365–370

Wilhelm K, Hofer U, Textor HJ, Böker T, Strunk H, Schild HH. Nonsurgical fluoroscopically guided dacryocystoplasty of common canalicular obstructions. Cardiovasc Intervent Radiol 2000;23:1–8

Wilhelm KE, Hofer U, Textor J, Loeffler K, Urbach H, Schild HH. Antegrade transcanalicular dacryocystoplasty of nasolacrimal duct obstructions. Radiology 2000;217(P):324

Wilhelm K, Loef f ler K, Urbach H, Schild H. Complete tear duct obstruction: treatment with lacrimal polyurethane stent implantation. Cardiovasc Intervent Radiol 2002;25: S149

Wilhelm K, Loeffler K, Urbach H, Schild H. Behandlung von Tränenwegsverschlüssen mit dem PBN Wilhelm TearLeader Stent: Erste Ergebnisse. Fortschr Röntgenstr 2003;175 S1:152–153

Yazici Z, Yazici B, Parlak M, Tuncel E, Ertürk H. Treatment of nasolacrimal duct obstruction with polyurethane stent placement: long-term results. AJR 2002;179:491–494

A

abscess 76

advanced trauma life support (ATLS) protocol 91

afferent papillary defect (APD) 95 agger nasi 63, 82

– cell 80 amethocaine 78

amorphous core proteins 23 amoxicillin 70

anterior lacrimal crest 70 APD, see afferent papillary defect arteriovenous anastomoses 10 ATLS, see advanced trauma

life support

B

C

CALT, see conjunctiva-associated lymphoid tissue

canalicular

– infections 130

– injury 98

canaliculodacryocystorhinostomy 50, 119, 128

canaliculoplasty 112 canaliculus 93, 98

cartilage containing nasal septal flap 123

caruncle 133

CDCR, see Conjunctivodacryocysorhinostomy

cervical spine trauma 92

88, 89, 100, 105, 112, 114, 116, 117, 123, 125, 128, 133, 137-140, 147,148, 152, 153

computed tomography (CT) 41 congenital

– dacryostenosis 148

– nasolacrimal duct obstruction 53 congestant eyedrops 148, 152 conjunctiva-associated lymphoid tissue

(CALT) 26 conjunctival flap 122, 123 conjunctivitis 30, 140

conjunctivodacryocysorhinostomy (CDCR) 50, 101, 119, 124, 128 conjunctivorhinostomy 119, 120,

123

– flaps 123

craniofacial abnormalities 69 Crawford

– intubation system 96

Crista maxillaris 63

CT, see computed tomography

D

dacryocystorhinostomy (DCR) 16, 20, 76, 105, 132

dacryoendoscopy 106, 109, 112

DCG, see digital subtraction dacryocystography

dexamethasone 116 diagnostic tests (overview) 32

digital subtraction dacryocystography

– sicca syndrome, see also keratoconjunctivitis sicca

– syndrome 34, 48

E

EALT, see eye-associated lymphoid

mucosa-associated lymphoid tissue

MUCs, see membrane bound mucins mushroom stent 150, 152

N

NLDS, see nasolacrimal duct system

polyvinylchloride tubing catheter 144

primary acquired nasolacrimal duct

Q

quartz fiber 107

R

retrograde canaliculography 130 rhinosinusitis 78

rhinostomy 74, 76, 80, 82, 83

S

scanning electron microscopy

157

SEM, see scanning electron microscopy

systemic antibiotics 54

T

TALT, see tear-duct-associated